Home > Compound List > Product Information
Tetracycline hydrochloride_Molecular_structure_CAS_64-75-5)
Click picture or here to close

Tetracycline hydrochloride

Catalog No. T9823 Name Sigma Aldrich
CAS Number 64-75-5 Website http://www.sigmaaldrich.com
M. F. C22H25ClN2O8 Telephone 1-800-521-8956
M. W. 480.8955 Fax
Purity ≥95% Email
Storage Chembase ID: 73266

SYNONYMS

Title
四环素 盐酸盐
IUPAC name
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
IUPAC Traditional name
tetracycline hydrochloride

DATABASE IDS

MDL Number MFCD00078142
CAS Number 64-75-5
PubChem SID 24900607
Beilstein Number 3844873
EC Number 200-593-8

PROPERTIES

Empirical Formula (Hill Notation) C22H24N2O8 · HCl
Grade Biotechnology Performance Certified
Impurities endotoxin, tested
Purity ≥95%
Suitability cell culture tested
Melting Point 220-223 °C(lit.)
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
RTECS QI9100000
Safety Statements 26-36
Storage Temperature -20°C
German water hazard class 2

DETAILS

Description (English)
Biochem/physiol Actions
Mode of Action: Inhibits protein synthesis (elongation) by preventing binding of aminoacyl-tRNA to the 30S subunit. Antimicrobial spectrum: Gram-negative and Gram-positive bacteria.Mode of Resistance: Loss of cell wall permeability.
Tetracycline inhibits bacterial protein synthesis elongation at the level of aminoacyl-tRNA binding to the 30S ribosome. Tetracycline passively diffuses through porin channels in the bacterial cell membrane. It also binds to the bacterial 50S ribosomal subunit which may alter the cytoplasmic membrane, causing intracellular components to leak from bacterial cells1. Mode of resistance is loss of cell wall permeability.
Application
Tetracycline is a broad spectrum polyketide antibiotic. It is used clinically to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever and Brill-Zinsser disease. It is used to treat upper respiratory infections and acne1. It is used to study multidrug resistance2 as well as potential side effects such as acute pancreatitis3. It has been used in target and resistance based mechanistic studies of novel antibiotics4.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information
Description (简体中文)
Biochem/physiol Actions
Mode of Action: Inhibits protein synthesis (elongation) by preventing binding of aminoacyl-tRNA to the 30S subunit. Antimicrobial spectrum: Gram-negative and Gram-positive bacteria.Mode of Resistance: Loss of cell wall permeability.
Tetracycline inhibits bacterial protein synthesis elongation at the level of aminoacyl-tRNA binding to the 30S ribosome. Tetracycline passively diffuses through porin channels in the bacterial cell membrane. It also binds to the bacterial 50S ribosomal subunit which may alter the cytoplasmic membrane, causing intracellular components to leak from bacterial cells1. Mode of resistance is loss of cell wall permeability.
Application
Tetracycline is a broad spectrum polyketide antibiotic. It is used clinically to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever and Brill-Zinsser disease. It is used to treat upper respiratory infections and acne1. It is used to study multidrug resistance2 as well as potential side effects such as acute pancreatitis3. It has been used in target and resistance based mechanistic studies of novel antibiotics4.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information

REFERENCES